Uploaded August 2026 | Updated September 2026, 2 weeks ago
The 2nd of 4 in our Prostate Cancer Conversation series in partnership with Omega Psi Phi Fraternity, Inc. In this discussion Dr. Ricky Ashby discusses Detection and Diagnosis of Prostate Cancer and a Prostate cancer survivor shares his experience.
Prostate cancer often develops without noticeable symptoms, making early detection and informed screening decisions especially important.
In this community conversation, Mayo Clinic experts and a prostate cancer survivor discuss how prostate cancer is detected, diagnosed and monitored. Learn how the PSA blood test is used, when screening may begin, what symptoms can occur, and how MRI, biopsy, Gleason scores, genetic testing and advanced imaging help guide care.
You’ll also hear a personal survivor story about recognizing changes, seeking medical evaluation, comparing treatment options and finding support from family and community.
Topics include:
• PSA testing and prostate cancer screening
• When to talk with your doctor about screening
• Early- and late-stage prostate cancer symptoms
• MRI, biopsy and Gleason scoring
• Low-, intermediate- and high-risk prostate cancer
• Active surveillance and treatment decisions
• Genetic testing and advanced imaging
• A survivor’s diagnosis and radiation treatment experience
• Community research and clinical study opportunities
This program is presented through a collaboration between Mayo Clinic and Omega Psi Phi Fraternity, Incorporated, to help communities better understand prostate cancer risk, screening and survivorship.
This video is for general educational purposes and does not replace medical advice. Talk with your healthcare professional about your individual risk factors and screening options.0:00 Welcome and Event Overview
1:14 Cancer Conversation Goals and Agenda
2:38 Pre-Event Knowledge Survey
5:04 Prostate Cancer Detection and Diagnosis
6:13 What Prostate Cancer Screening Means
7:48 Understanding the PSA Blood Test
9:33 When Prostate Cancer Screening Should Begin
10:54 Symptoms and Importance of Early Detection
12:39 Screening Benefits, Risks and Overtreatment
14:12 Symptoms of Advanced Prostate Cancer
15:23 MRI, Biopsy and Diagnostic Imaging
18:10 Gleason Scores and Cancer Staging
19:31 Low, Intermediate and High-Risk Disease
21:46 Advanced Imaging and Genetic Testing
26:44 A Survivor’s Prostate Cancer Journey
39:41 Audience Questions About Screening and Surgery
48:25 Community Research and Engagement Opportunities
53:48 Vitamin D Prostate Cancer Research Study
57:39 Closing Remarks and Resources
From Mayo Clinic to your inbox (free):
mayocl.in/3e71zfi
Visit Mayo Clinic:
mayocl.in/2COVmlm
Connect with Mayo Clinic:
Facebook: facebook.com/mayoclinic
Instagram: instagram.com/mayoclinic
X: https://x.com/MayoClinic
Threads: threads.net/@mayoclinic
The 2nd of 4 in our Prostate Cancer Conversation series in partnership with Omega Psi Phi Fraternity, Inc. In this discussion Dr. Ricky Ashby discusses Detection and Diagnosis of Prostate Cancer and a Prostate cancer survivor shares his experience.
Prostate cancer often develops without noticeable symptoms, making early detection and informed screening decisions especially important.
In this community conversation, Mayo Clinic experts and a prostate cancer survivor discuss how prostate cancer is detected, diagnosed and monitored. Learn how the PSA blood test is used, when screening may begin, what symptoms can occur, and how MRI, biopsy, Gleason scores, genetic testing and advanced imaging help guide care.
You’ll also hear a personal survivor story about recognizing changes, seeking medical evaluation, comparing treatment options and finding support from family and community.
Topics include:
• PSA testing and prostate cancer screening
• When to talk with your doctor about screening
• Early- and late-stage prostate cancer symptoms
• MRI, biopsy and Gleason scoring
• Low-, intermediate- and high-risk prostate cancer
• Active surveillance and treatment decisions
• Genetic testing and advanced imaging
• A survivor’s diagnosis and radiation treatment experience
• Community research and clinical study opportunities
This program is presented through a collaboration between Mayo Clinic and Omega Psi Phi Fraternity, Incorporated, to help communities better understand prostate cancer risk, screening and survivorship.
This video is for general educational purposes and does not replace medical advice. Talk with your healthcare professional about your individual risk factors and screening options.0:00 Welcome and Event Overview
1:14 Cancer Conversation Goals and Agenda
2:38 Pre-Event Knowledge Survey
5:04 Prostate Cancer Detection and Diagnosis
6:13 What Prostate Cancer Screening Means
7:48 Understanding the PSA Blood Test
9:33 When Prostate Cancer Screening Should Begin
10:54 Symptoms and Importance of Early Detection
12:39 Screening Benefits, Risks and Overtreatment
14:12 Symptoms of Advanced Prostate Cancer
15:23 MRI, Biopsy and Diagnostic Imaging
18:10 Gleason Scores and Cancer Staging
19:31 Low, Intermediate and High-Risk Disease
21:46 Advanced Imaging and Genetic Testing
26:44 A Survivor’s Prostate Cancer Journey
39:41 Audience Questions About Screening and Surgery
48:25 Community Research and Engagement Opportunities
53:48 Vitamin D Prostate Cancer Research Study
57:39 Closing Remarks and Resources
From Mayo Clinic to your inbox (free):
mayocl.in/3e71zfi
Visit Mayo Clinic:
mayocl.in/2COVmlm
Connect with Mayo Clinic:
Facebook: facebook.com/mayoclinic
Instagram: instagram.com/mayoclinic
X: https://x.com/MayoClinic
Threads: threads.net/@mayoclinic
